Earnings History Data for Accelerate Diagnostics, Inc. (AXDX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28-03-2024 | AH | AXDX | Accelerate Diagnostics, Inc. | 13.97 | -0.89 | -0.62 | -1.40 | Accelerate Diagnostics GAAP EPS of -$0.89 misses by $0.27, revenue of $3M misses by $0.45M [3/28/2024 4:16 PM] |
0.99 | -0.02 (-1.98%) |
0.98 | -0.01 (-1.01%) |
0.83 - 11.90 | 84,363 | 70,000 | 2,236 | ||
| 09-11-2023 | AH | AXDX | Accelerate Diagnostics, Inc. | 82.33 | -0.92 | -0.94 | -1.80 | Accelerate Diagnostics GAAP EPS of $0.06 beats by $1.13, revenue of $3.3M misses by $0.25M [11/9/2023 4:15 PM] |
5.81 | -0.09 (-1.53%) |
0.0 | 0.0 (0.00%) |
4.50 - 15.60 | 11,114 | 10,000 | 0 | ||
| 10-08-2023 | AH | AXDX | Accelerate Diagnostics, Inc. | 98.18 | -2.36 | -1.50 | -2.40 | Accelerate Diagnostics GAAP EPS of -$2.36 misses by $0.96, revenue of $2.92M misses by $0.68M [8/10/2023 4:13 PM] |
7.20 | 0.35 (5.11%) |
6.40 | -0.45 (-6.57%) |
4.50 - 37.37 | 15,758 | 30,000 | 459 | ||
| 11-05-2023 | AH | 4:05 PM ET (May 11) |
AXDX | Accelerate Diagnostics, Inc. | 78.70 | -0.17 | -0.17 | -0.25 | Accelerate Diagnostics GAAP EPS of -$0.17 misses by $0.03, revenue of $2.81M misses by $0.54M [5/11/2023 4:22 PM] |
0.7506 | 0.0 (0.05%) |
0.75 | 0.0 (-0.03%) |
0.45 - 3.74 | 230,567 | 160,000 | 3,520 | |
| 29-03-2023 | AH | 4:05 PM ET (Mar 29) |
AXDX | Accelerate Diagnostics | 48.00 | -0.14 | -0.16 | 0.00 | Accelerate Diagnostics GAAP EPS of -$0.76 in-line, revenue of $12.75M beats by $0.1M [3/29/2023 4:16 PM] |
0.7089 | 0.21 (41.27%) |
0.54 | 0.04 (7.17%) |
0.45 - 3.74 | 2,354,534 | 190,000 | 177 | |
| 14-11-2022 | AH | 4:05 PM ET (Nov 14) |
AXDX | Accelerate Diagnostics, Inc. | 141.66 | -0.18 | -0.21 | -0.15 | Accelerate Diagnostics GAAP EPS of -$0.18, revenue of $2.96M [11/14/2022 4:11 PM] |
1.21 | -0.29 (-19.33%) |
1.45 | -0.05 (-3.33%) |
0.50 - 7.19 | 414,076 | 150,000 | 945 | |
| 16-05-2022 | AH | 4:05 PM ET (May 16) |
AXDX | Accelerate Diagnostics, Inc. | 47.11 | -0.25 | -0.32 | -0.41 | Accelerate Diagnostics GAAP EPS of -$0.21 beats by $0.09, revenue of $2.96M beats by $0.01M [5/16/2022 4:16 PM] |
0.6001 | -0.01 (-1.62%) |
0.73 | 0.04 (5.78%) |
0.58 - 9.36 | 577,543 | 550,000 | 530 | |
|
||||||||||||||||||
| 08-03-2022 | AH | 4:05 PM ET (Mar 8) |
AXDX | Accelerate Diagnostics, Inc. | 162.65 | -0.23 | -0.30 | -0.33 | Accelerate Diagnostics reports Q4 results [3/8/2022 4:34 PM] |
2.19 | -0.08 (-3.74%) |
2.14 | -0.13 (-5.73%) |
2.04 - 10.09 | 183,495 | 250,000 | 2,912 | |
| 09-11-2021 | AH | 4:05 PM ET (Nov 9) |
AXDX | Accelerate Diagnostics, Inc. | 410.01 | -0.15 | -0.35 | -0.33 | Accelerate Diagnostics EPS beats by $0.17, misses on revenue [11/9/2021 4:29 PM] |
6.13 | -0.06 (-0.97%) |
6.19 | 0.0 (0.00%) |
5.15 - 15.60 | 457,453 | 250,000 | 2,798 | |
| 05-08-2021 | AH | 4:05 PM ET (Aug 5) |
AXDX | Accelerate Diagnostics, Inc. | 463.32 | -0.36 | -0.35 | -0.35 | Accelerate Diagnostics EPS misses by $0.03, misses on revenue [8/5/2021 4:20 PM] |
7.05 | -0.28 (-3.82%) |
7.10 | -0.23 (-3.14%) |
6.44 - 17.82 | 70,935 | 110,000 | 1,463 | |
| 06-05-2021 | AH | 4:15 PM ET (May 6) |
AXDX | Accelerate Diagnostics, Inc. | 450.20 | -0.41 | -0.33 | -0.39 | Accelerate Diagnostics EPS misses by $0.08, misses on revenue [5/6/2021 4:48 PM] |
7.35 | 0.06 (0.75%) |
7.50 | 0.21 (2.81%) |
6.82 - 19.11 | 246,112 | 180,000 | 1,671 | |
|
||||||||||||||||||
| 23-02-2021 | AH | 4:30 PM ET (Feb 23) |
AXDX | Accelerate Diagnostics, Inc. | 734.45 | -0.33 | -0.31 | -0.39 | Accelerate Diagnostics EPS misses by $0.01, misses on revenue [2/23/2021 4:21 PM] |
11.44 | 0.29 (2.60%) |
11.00 | -0.15 (-1.35%) |
4.53 - 19.11 | 492,445 | 396,804 | 467 | |
| 05-11-2020 | AH | 4:15 PM ET (Nov 5) |
AXDX | Accelerate Diagnostics, Inc. | 547.21 | -0.33 | -0.33 | -0.37 | Accelerate Diagnostics EPS in-line, beats on revenue [11/5/2020 5:31 PM] |
9.50 | -0.36 (-3.67%) |
0.0 | 0.0 (0.00%) |
4.53 - 19.11 | 145,458 | 159,451 | 0 | |
|
|
||||||||||||||||||
| 06-08-2020 | AH | 4:00 PM ET (Aug 6) |
AXDX | Accelerate Diagnostics, Inc. | 831.82 | -0.35 | -0.34 | -0.38 | Accelerate Diagnostics EPS misses by $0.01, misses on revenue [8/6/2020 4:54 PM] |
16.36 | 1.66 (11.26%) |
17.28 | 2.58 (17.55%) |
4.53 - 22.13 | 237,634 | 286,901 | 6,222 | |
|
|
||||||||||||||||||